Steinberg, Helmut O.

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Riesmeyer, J. S., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 3,163

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

Steinberg, H. O., Chaker, H., Leaming, R., Johnson, A., Brechtel, G., & Baron, A. D. (1996) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 1,687

Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation

Steinberg, H. O., Tarshoby, M., Monestel, R., Hook, G., Cronin, J., Johnson, A., Bayazeed, B., & Baron, A. D. (1997) · Journal of Clinical Investigation

Nitric Oxide and Endothelin EffectsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 761

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Gerstein, H. C., Colhoun, H. M., Dagenais, G. R., Diaz, R., Lakshmanan, M., Pais, P., Probstfield, J., Botros, F. T., Riddle, M. C., Rydén, L., et al. (2019) · The Lancet

Diabetes Treatment and ManagementChronic Kidney Disease and Diabetes

Cited by 638

Repeatability Characteristics of Simple Indices of Insulin Resistance: Implications for Research Applications

Mather, K. J., Hunt, A. E., Steinberg, H. O., Paradisi, G., Hook, G., Katz, A., Quon, M. J., & Baron, A. D. (2001) · The Journal of Clinical Endocrinology & Metabolism

Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research

Cited by 363

Screening for coronary artery disease in patients with diabetes

Bax, J. J., Young, L. H., Frye, R. L., Bonow, R. O., Steinberg, H. O., & Barrett, E. J. (2007) · Diabetes Care

Cardiac Imaging and DiagnosticsDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 251

Adipose tissue production of hepatocyte growth factor contributes to elevated serum HGF in obesity

Bell, L. N., Ward, J. L., Degawa-Yamauchi, M., Bovenkerk, J. E., Jones, R., Cacucci, B. M., Gupta, C. E., Sheridan, C., Sheridan, K., Shankar, S. S., et al. (2006) · American Journal of Physiology-Endocrinology and Metabolism

Adipokines, Inflammation, and Metabolic DiseasesLiver physiology and pathology

Cited by 121

Insulin resistance in the vasculature

Mather, K. J., Steinberg, H. O., & Baron, A. D. (2013) · Journal of Clinical Investigation

Diabetes, Cardiovascular Risks, and LipoproteinsNitric Oxide and Endothelin Effects

Cited by 120

The Effect of Intentional Weight Loss on Fracture Risk in Persons With Diabetes: Results From the Look AHEAD Randomized Clinical Trial

Johnson, K. C., Bray, G. A., Cheskin, L. J., Clark, J. M., Egan, C. M., Foreyt, J. P., Garcia, K. R., Glasser, S., Greenway, F. L., Gregg, E. W., et al. (2017) · Journal of Bone and Mineral Research

Bone health and osteoporosis researchDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 104